Mark Simon Biography and Net Worth

Mark is a Strategic Advisor to the Founder and CEO of Sun Pharmaceutical Industries Ltd., the largest pharmaceutical company in India, and a board observer of the Sun Pharma Advanced Research Company Ltd., both public companies in India, where Mr. Simon is focused on accelerating their innovation initiatives. He is also a consultant to Stifel Nicolaus & Company (NYSE: SF) and a co-founder of Torreya Partners, LLC, a global investment banking firm serving companies in the life sciences industry that was purchased by Stifel in 2023. Before co-founding Torreya, Mr. Simon was a managing director and head of investment banking life sciences at Citigroup from 2002 to 2005, where he covered global pharmaceutical companies with a focus on large-capitalization players in the U.S., Europe, and Japan. Prior to Citigroup, Mr. Simon served as a Managing Director at Robertson Stephens in San Francisco and New York, responsible for covering the biotechnology investment banking sector. During his tenure overseeing the group, he was involved in raising 45% of all biotechnology dollars raised in the U.S. from 1999-2001. Before joining the investment banking group at Robertson, Mr. Simon was a senior biotechnology research analyst at Robertson Stephens and was named a Wall Street All-Star Analyst for three years in a row. He began his career at Kidder Peabody as a biotechnology research associate in 1984 and participated in the IPO of Genzyme and the early financings for companies such as Amgen. Mr. Simon currently serves on the board of directors of Cabaletta Bio, Inc., a clinical-stage biotech focusing on curative, targeted cell therapies for patients with autoimmune diseases. Mr. Simon also serves on the boards of directors of several disease advocacy and philanthropic foundations in oncology, CNS/neuroscience, and other areas and on an advisory board at the Washington University School of Medicine in St. Louis. He received his MBA from Harvard Business School and his B.A. from Columbia College in NYC.